Development of Oral, Potent, and Selective CK1α Degraders for AML Therapy
Lu Huang(Shanxi Medical University), Wenchao Lu, Ping Yang(Institute for Biomedicine), Qiangqiang Han, Baishan Jiang(Wuhan University), Lixin Zhou(University of Shanghai for Science and Technology), Xi Chen(University of Iowa), Yuhang Liu(Beijing Institute of Technology), Lü Chen(Wuhan University), Jiayi Lu(Veracyte (United States)), Yanli Sun(Qingdao University), Lanlan Li, Zhixiang Guo(Anhui Medical University), Weiye Lin(ShanghaiTech University), Jing Yang(Tongji University), Zhe Wang(Xijing Hospital), Taiting Shi(Wenzhou Medical University), Linhui Cao(Yantai University), Shuo Zhang(Shanghai Jiao Tong University), Xiaozhong Peng(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 16
Related Papers
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
|eLife|2012|2.1k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k
Vapor-assisted deposition of highly efficient, stable black-phase FAPbI <sub>3</sub> perovskite solar cells
|Science|2020|786